Laminin gamma 2 monomer

1. Laminin gamma 2 monomer predicts hepatocellular carcinoma in humans (5.5% vs. 1.0% for high vs. low LG2m).

   Humansin chronic hepatitis B patients with nonhigh PAGE-Bserum5 years

   The Clinical Utility of Adding Laminin Gamma 2 Monomer to the PAGE-B Score for Hepatocellular Carcinoma Surveillance in Chronic Hepatitis B

   Journal of gastroenterology and hepatology·8 Oct 2026

2. Laminin gamma 2 monomer raises the risk of hepatocellular carcinoma in humans (adjusted HR, 4.40; 95% CI, 1.26-15.44).

   Humansin chronic hepatitis B patients with nonhigh PAGE-B scoreserum

   The Clinical Utility of Adding Laminin Gamma 2 Monomer to the PAGE-B Score for Hepatocellular Carcinoma Surveillance in Chronic Hepatitis B

   Journal of gastroenterology and hepatology·8 Oct 2026

More on Hepatocellular carcinoma